These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9774490)

  • 1. Effects of cardio-pulmonary bypass on vancomycin plasma concentration decay.
    Miglioli PA; Merlo F; Grabocka E; Padrini R
    Pharmacol Res; 1998 Oct; 38(4):275-8. PubMed ID: 9774490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cefazolin concentrations in serum during cardiopulmonary bypass surgery.
    Miglioli PA; Merlo F; Calabrò GB; Allerberger F; Fille M
    Drugs Exp Clin Res; 2005; 31(1):29-33. PubMed ID: 15921027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alteration of vancomycin pharmacokinetics during cardiopulmonary bypass in patients undergoing cardiac surgery.
    Ortega GM; Martí-Bonmatí E; Guevara SJ; Gómez IG
    Am J Health Syst Pharm; 2003 Feb; 60(3):260-5. PubMed ID: 12613235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vancomycin sequestration during cardiopulmonary bypass surgery.
    Krivoy N; Yanovsky B; Kophit A; Zaher A; Bar-El Y; Adler Z; Gaitini L; Milo S
    J Infect; 2002 Aug; 45(2):90-5. PubMed ID: 12217710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of cardiopulmonary bypass on teicoplanin serum disposition.
    Miglioli PA; Merlo F; Campanile F; Padrini R
    Int J Clin Pharmacol Res; 1995; 15(1):23-5. PubMed ID: 7490171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraoperative vancomycin pharmacokinetics in cardiac surgery with or without cardiopulmonary bypass.
    Cotogni P; Passera R; Barbero C; Gariboldi A; Moscato D; Izzo G; Rinaldi M
    Ann Pharmacother; 2013 Apr; 47(4):455-63. PubMed ID: 23512663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy of post-cardiopulmonary bypass dosing of vancomycin in cardiac surgery.
    Raikhelkar JK; Reich DL; Schure R; Varghese R; Bodian C; Scurlock C
    Semin Cardiothorac Vasc Anesth; 2010 Dec; 14(4):301-4. PubMed ID: 20841364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Teicoplanin concentrations in serum, pericardium, pericardial fluid and thoracic wall fat in patients undergoing cardio-pulmonary bypass surgery.
    Miglioli PA; Merlo F; Fabbri A; Padrini R
    J Antimicrob Chemother; 1997 Feb; 39(2):229-33. PubMed ID: 9069544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Weight-based versus set dosing of vancomycin for coronary artery bypass grafting or aortic valve surgery.
    Hafermann MJ; Kiser TH; Lyda C; Fish DN; Barber GR; Wempe MF; Cleveland JC
    J Thorac Cardiovasc Surg; 2014 Jun; 147(6):1925-30. PubMed ID: 24521953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effect of Modified Ultrafiltration on Serum Vancomycin Levels During Cardiopulmonary Bypass in Cardiac Surgery.
    Crimi E; Hernandez-Barajas D; Seller A; Ashton J; Martin M; Vasilopoulos T; Gravenstein N
    J Cardiothorac Vasc Anesth; 2019 Jan; 33(1):102-106. PubMed ID: 30143360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of cardiopulmonary bypass on vancomycin and netilmicin disposition.
    Klamerus KJ; Rodvold KA; Silverman NA; Levitsky S
    Antimicrob Agents Chemother; 1988 May; 32(5):631-5. PubMed ID: 3395099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum concentrations and pharmacokinetics of moxifloxacin in patients undergoing coronary artery bypass graft surgery with cardiopulmonary bypass.
    Wiesner G; Martin K; Gertler R; Braun SL; Tassani P; Lange R; Gruber M
    Int J Antimicrob Agents; 2013 May; 41(5):473-6. PubMed ID: 23481660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vancomycin serum concentrations in pediatric oncologic/hematologic intensive care patients.
    Silva DC; Seixas GT; Araujo OR; Arduini RG; Carlesse FA; Petrilli AS
    Braz J Infect Dis; 2012; 16(4):361-5. PubMed ID: 22846125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of vancomycin administered as prophylaxis before cardiac surgery.
    Kitzes-Cohen R; Farin D; Piva G; Ivry S; Sharony R; Amar R; Uretzky G
    Ther Drug Monit; 2000 Dec; 22(6):661-7. PubMed ID: 11128233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinectics of vancomycin and amikacin in the subeschar tissue fluid in patients with severe burn.
    Yang RH; Rong XZ; Hua R; Zhang T
    Burns; 2009 Feb; 35(1):75-9. PubMed ID: 18789586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implementation of a protocol for administration of vancomycin by continuous infusion: pharmacokinetic, pharmacodynamic and toxicological aspects.
    Ampe E; Delaere B; Hecq JD; Tulkens PM; Glupczynski Y
    Int J Antimicrob Agents; 2013 May; 41(5):439-46. PubMed ID: 23523733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of intravenous vancomycin in pediatric cardiopulmonary bypass surgery.
    Hatzopoulos FK; Stile-Calligaro IL; Rodvold KA; Sullivan-Bolyai J; Del Nido P; Levitsky S
    Pediatr Infect Dis J; 1993 Apr; 12(4):300-4. PubMed ID: 8483624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subtherapeutic serum vancomycin concentrations during on-line hemodiafiltration.
    Sombolos KI; Fragidis SK; Bamichas GI; Hatsiou VN; Rizos AK; Natse TA; Fytili CI
    ASAIO J; 2011; 57(6):507-10. PubMed ID: 21946313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of cardiopulmonary bypass on cefuroxime plasma concentration and pharmacokinetics in patients undergoing coronary surgery.
    Ferreira F; Santos S; Nascimento J; Strabelli T; Carmona M
    Eur J Cardiothorac Surg; 2012 Aug; 42(2):300-5. PubMed ID: 22290920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Desired vancomycin trough serum concentration for treating invasive methicillin-resistant Staphylococcal infections.
    Frymoyer A; Guglielmo BJ; Hersh AL
    Pediatr Infect Dis J; 2013 Oct; 32(10):1077-9. PubMed ID: 23652479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.